220 related articles for article (PubMed ID: 25030302)
21. Recognition of privileged structures by G-protein coupled receptors.
Bondensgaard K; Ankersen M; Thøgersen H; Hansen BS; Wulff BS; Bywater RP
J Med Chem; 2004 Feb; 47(4):888-99. PubMed ID: 14761190
[TBL] [Abstract][Full Text] [Related]
22. Nonlinear scoring functions for similarity-based ligand docking and binding affinity prediction.
Brylinski M
J Chem Inf Model; 2013 Nov; 53(11):3097-112. PubMed ID: 24171431
[TBL] [Abstract][Full Text] [Related]
23. Structural features for functional selectivity at serotonin receptors.
Wacker D; Wang C; Katritch V; Han GW; Huang XP; Vardy E; McCorvy JD; Jiang Y; Chu M; Siu FY; Liu W; Xu HE; Cherezov V; Roth BL; Stevens RC
Science; 2013 May; 340(6132):615-9. PubMed ID: 23519215
[TBL] [Abstract][Full Text] [Related]
24. Reliability of Docking-Based Virtual Screening for GPCR Ligands with Homology Modeled Structures: A Case Study of the Angiotensin II Type I Receptor.
Chen H; Fu W; Wang Z; Wang X; Lei T; Zhu F; Li D; Chang S; Xu L; Hou T
ACS Chem Neurosci; 2019 Jan; 10(1):677-689. PubMed ID: 30265513
[TBL] [Abstract][Full Text] [Related]
25. Benchmarking GPCR homology model template selection in combination with de novo loop generation.
Szwabowski GL; Castleman PN; Sears CK; Wink LH; Cole JA; Baker DL; Parrill AL
J Comput Aided Mol Des; 2020 Oct; 34(10):1027-1044. PubMed ID: 32737667
[TBL] [Abstract][Full Text] [Related]
26. Incorporating backbone flexibility in MedusaDock improves ligand-binding pose prediction in the CSAR2011 docking benchmark.
Ding F; Dokholyan NV
J Chem Inf Model; 2013 Aug; 53(8):1871-9. PubMed ID: 23237273
[TBL] [Abstract][Full Text] [Related]
27. Molecular modeling of vasopressin receptor and in silico screening of V1b receptor antagonists.
Hagiwara Y; Ohno K; Kamohara M; Takasaki J; Watanabe T; Fukunishi Y; Nakamura H; Orita M
Expert Opin Drug Discov; 2013 Aug; 8(8):951-64. PubMed ID: 23682717
[TBL] [Abstract][Full Text] [Related]
28. Multi-state modeling of G-protein coupled receptors at experimental accuracy.
Heo L; Feig M
Proteins; 2022 Nov; 90(11):1873-1885. PubMed ID: 35510704
[TBL] [Abstract][Full Text] [Related]
29. Template selection and refinement considerations for modelling aminergic GPCR-ligand complexes.
Urmi KF; Finch AM; Griffith R
J Mol Graph Model; 2017 Sep; 76():488-503. PubMed ID: 28818718
[TBL] [Abstract][Full Text] [Related]
30. Protein-based virtual screening of chemical databases. II. Are homology models of G-Protein Coupled Receptors suitable targets?
Bissantz C; Bernard P; Hibert M; Rognan D
Proteins; 2003 Jan; 50(1):5-25. PubMed ID: 12471595
[TBL] [Abstract][Full Text] [Related]
31. Application of Monte Carlo-based receptor ensemble docking to virtual screening for GPCR ligands.
Vilar S; Costanzi S
Methods Enzymol; 2013; 522():263-78. PubMed ID: 23374190
[TBL] [Abstract][Full Text] [Related]
32. Ligand-optimized homology models of D₁ and D₂ dopamine receptors: application for virtual screening.
Kołaczkowski M; Bucki A; Feder M; Pawłowski M
J Chem Inf Model; 2013 Mar; 53(3):638-48. PubMed ID: 23398329
[TBL] [Abstract][Full Text] [Related]
33. A benchmarking study on virtual ligand screening against homology models of human GPCRs.
Lim VJY; Du W; Chen YZ; Fan H
Proteins; 2018 Sep; 86(9):978-989. PubMed ID: 30051928
[TBL] [Abstract][Full Text] [Related]
34. Dynamics and structural determinants of ligand recognition of the 5-HT6 receptor.
Vass M; Jójárt B; Bogár F; Paragi G; Keserű GM; Tarcsay Á
J Comput Aided Mol Des; 2015 Dec; 29(12):1137-49. PubMed ID: 26572911
[TBL] [Abstract][Full Text] [Related]
35. FlexE: efficient molecular docking considering protein structure variations.
Claussen H; Buning C; Rarey M; Lengauer T
J Mol Biol; 2001 Apr; 308(2):377-95. PubMed ID: 11327774
[TBL] [Abstract][Full Text] [Related]
36. Predicted 3D structures for adenosine receptors bound to ligands: comparison to the crystal structure.
Goddard WA; Kim SK; Li Y; Trzaskowski B; Griffith AR; Abrol R
J Struct Biol; 2010 Apr; 170(1):10-20. PubMed ID: 20079848
[TBL] [Abstract][Full Text] [Related]
37. Status of GPCR modeling and docking as reflected by community-wide GPCR Dock 2010 assessment.
Kufareva I; Rueda M; Katritch V; Stevens RC; Abagyan R;
Structure; 2011 Aug; 19(8):1108-26. PubMed ID: 21827947
[TBL] [Abstract][Full Text] [Related]
38. Drug design strategies for targeting G-protein-coupled receptors.
Klabunde T; Hessler G
Chembiochem; 2002 Oct; 3(10):928-44. PubMed ID: 12362358
[TBL] [Abstract][Full Text] [Related]
39. Can molecular dynamics simulations improve the structural accuracy and virtual screening performance of GPCR models?
Kapla J; Rodríguez-Espigares I; Ballante F; Selent J; Carlsson J
PLoS Comput Biol; 2021 May; 17(5):e1008936. PubMed ID: 33983933
[TBL] [Abstract][Full Text] [Related]
40. Structural basis for ligand binding and specificity in adrenergic receptors: implications for GPCR-targeted drug discovery.
Huber T; Menon S; Sakmar TP
Biochemistry; 2008 Oct; 47(42):11013-23. PubMed ID: 18821775
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
